Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad,
India

EQS-News: Olympus Corp. / Key word(s): Miscellaneous
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad,
India

12.06.2024 / 14:30 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad,
India


Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=016ba4a1f00817e8a3aa042e15d14dbb
Image title: Endoscopy Engineering support services in India

Tokyo, Japan, 12 June 2024, JCN Newswire - Olympus Corporation (Olympus), a
global MedTech Company committed to making people's lives healthier, safer
and more fulfilling, today announced its strategic initiative to establish
an R&D Offshore Development Center (ODC) in Hyderabad, India. This decision
comes as a result of a strategic agreement with global technology company
HCLTech, aimed at diversifying Olympus' innovation generation activities.

Establishing this R&D ODC in Hyderabad is part of Olympus' commitment to
leverag e global R&D talents and resources driving advancements in medical
technology. Hyderabad is a major metropolitan area and is known as India's
MedTech hub, providing the talent needed for research and development
activities necessary for Olympus' expansion efforts.

Concurrent with the creation of the ODC, Olympus will also prepare for the
establishment of Olympus' in-house R&D center in the coming years. This
center would be in addition to the company's current R&D centers in Japan,
the United States, and Europe.

The company plans to further establish its presence in the country by
collaborating with AIG Hospitals, Hyderabad for joint research projects. By
partnering with one of India's premier healthcare institutions, Olympus aims
to leverage clinical expertise and insights to drive t he development of
innovative medical solutions that address the evolving needs of patients
worldwide.

Since establishing Olympus Medical Systems India Private Limited in 2009,
Olympus has continued to expand its operations in India and has achieved
growth with the support of its many stakeholders. These strategic
initiatives not only reinforce Olympus' commitment to advancing medical
technology but also strengthen its global footprint and enhance the
company's ability to deliver impactful healthcare solutions.

Comment from Andre Roggan, Chief Technology Officer at Olympus

'It is with great pleasure and excitement that we announce this agreement
with HCLTech, with whom we share a decade-long partnership in core
engineering and R&D services. I am confident that our collaboration will
enhance Olympus' engineering capabilities and unlock new innovations that
enable quality healthcare through technology.'

Comment from Mr. D. Sridhar Babu, Minister of Information Technology,
Electronics & Communications (ITE&C) and Industries & Commerce (I&C) of the
Government of Telangana

'We are thrilled that Olympus Corporation, one of the world's largest
medical device companies, has chosen Hyderabad for its first investment in
India with an R&D center, marking a significant milestone for our city's
medical devices ecosystem. With Hyderabad's robust infrastructure, strategic
location, and thriving community of innovative healthcare companies, this
investment is poised to be a game-changer for the medical devices sector in
India. We are confident that Olympus' advanced technologies and expertise
will significantly contribute to our vision of becoming a global hub for
medical device innovation and manufacturing. I welcome Olympus Corporation
to our ecosystem.'

About HCLTech

HCLTech is a global technology company, home to more than 227,000 people
across 60 countries, delivering industry-leading capabilities centered
around digital, engineering, cloud , and AI, powered by a broad portfolio of
technology services and products. HCLTech works with clients across all
major verticals, providing industry solutions for Financial Services,
Manufacturing, Life Sciences and Healthcare, Technology and Services,
Telecom and Media, Retail and CPG, and Public Services. Consolidated
revenues as of the 12 months ending March 2024 totalled $13.3 billion. To
learn how HCLTech can supercharge progress for you, visit hcltech.com.

About Olympus

At Olympus, we are committed to Our Purpose of making people's lives
healthier, safer and more fulfilling. As a global medical technology
company, we partner with healthcare professionals to provide best-in-class
solutions and services for early detection, diagnosis and minimally invasive
treatment, aiming to improve patient outcomes by elevating the standard of
care in targeted disease states. For more than 100 years, Olympus has
pursued a goal of contributing to society by producing products designed
with the purpose of delivering optimal outcomes for its customers around the
world. For more information, visit olympus-global.com and follow our global
X account: @Olympus_Corp.

Media contact:

Mail: Global-Public_Relations@olympus.com

Olympus Corp (TYO: 7733) (ADR: OLYMY) (STU: OLY1) (FRA: OLYS)
https://www.olympus-global.com


---------------------------------------------------------------------------

12.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

1923725 12.06.2024 CET/CEST